Wendy Li brings 10 years of clinical practice and over 20 years of hand-on experience in providing medical and scientific leadership in clinical research in oncology and other therapeutic areas, with previous experience in oncology clinical development at Genentech, Sanofi, and Pfizer. For the last two years, Dr. Li has been Medical Head and Vice President of Clinical Development for an EU Biotechnology start up where she provided medical and clinical guidance in the review and evaluation of immuno-oncology products. Prior to this position, she held a VP/CMO position with Sihuan Pharma/Co-Xuanzhu Pharma. She has provided leadership on global early and late stage clinical studies, responded to FDA/CFDA and related agencies, and advised clinical, marketing, regulatory, and pharmacovigilance teams. Dr. Li received her M.D. from the Sun Yat-Sen University of Medical Studies in China.
Wendy Li, M.D. Chief Medical Officer